Teva Can't End Inhaler Antitrust Suit But Gets Claim Nixed
By Matthew Perlman · November 7, 2024, 5:19 PM EST
A Massachusetts federal court refused Teva Pharmaceutical Industries Ltd.'s attempt to end a case accusing it of orchestrating a decade-long scheme to delay generic competition for its QVAR asthma inhalers, but...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login